Associated Formulations Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 15-11-2024
- Paid Up Capital ₹ 0.10 M
as on 15-11-2024
- Company Age 6 Year, 10 Months
- Last Filing with ROC 31 Mar 2023
- Revenue -24.15%
(FY 2023)
- Profit -9.40%
(FY 2023)
- Ebitda 48.57%
(FY 2023)
- Net Worth 40.56%
(FY 2023)
- Total Assets -21.77%
(FY 2023)
About Associated Formulations
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Pranshul Aggarwal, Rajesh Pandey, and Raghavendra Mohan serve as directors at the Company.
- CIN/LLPIN
U74999DL2018PTC329571
- Company No.
329571
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
17 Feb 2018
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
Delhi, India
- Telephone
- Email Address
- Website
-
- Social Media-
What products or services does Associated Formulations Private Limited offer?
Associated Formulations Private Limited offers a wide range of products and services, including Pain Relief Drugs & Pharmaceuticals, Diclofenac, TB, Tumor & Cancer Drugs, Anti Cancer Medicines, Osteoporosis Medications, Muscle Relaxant, Cardiovascular Drugs & Medication, Cholesterol Medicine, Juices, Soups & Soft Drinks, Instant Drink Mix.
Who are the key members and board of directors at Associated Formulations?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Pranshul Aggarwal  | Director | 17-Mar-2021 | Current |
| Rajesh Pandey | Director | Current | |
| Raghavendra Mohan | Director | 25-Jun-2022 | Current |
Financial Performance of Associated Formulations.
Associated Formulations Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 24.15% decrease. The company also saw a slight decrease in profitability, with a 9.4% decrease in profit. The company's net worth Soared by an impressive increase of 40.56%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Associated Formulations?
In 2023, Associated Formulations had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Associated Formulations?
Associated Formulations has a workforce of 9 employees as of Apr 08, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Associated Formulations, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Associated Formulations's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
